Detalhe da pesquisa
1.
Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
Semin Immunol
; 69: 101799, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37413923
2.
Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFß.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835342
3.
Eosinophils and eosinophil-associated diseases: An update.
J Allergy Clin Immunol
; 141(2): 505-517, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045815
4.
Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
J Allergy Clin Immunol
; 141(5): 1774-1785.e7, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28734845
5.
Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating ß2-integrin-dependent function in human eosinophils.
J Allergy Clin Immunol
; 141(6): 2196-2207, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28888781
6.
CD8(+) T cells sabotage their own memory potential through IFN-γ-dependent modification of the IL-12/IL-15 receptor α axis on dendritic cells.
J Immunol
; 188(8): 3639-47, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22430740
7.
Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens.
J Immunol
; 186(1): 275-83, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21106849
8.
Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-ß blockade during the perioperative period of tumor resection.
J Immunol
; 186(6): 3309-16, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21289306
9.
Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells.
Front Immunol
; 14: 1283370, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928558
10.
Siglecs in allergy and asthma.
Mol Aspects Med
; 90: 101104, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835621
11.
NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells.
Mol Immunol
; 155: 1-6, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634520
12.
Drug delivery targets and strategies to address mast cell diseases.
Expert Opin Drug Deliv
; 20(2): 205-222, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629456
13.
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells.
Cells
; 11(7)2022 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406705
14.
Priming with very low-affinity peptide ligands gives rise to CD8(+) T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)ß-mediated suppression.
Cancer Immunol Immunother
; 60(11): 1543-51, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21681376
15.
CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-ß (TGF-ß)-mediated suppression.
Cancer Immunol Immunother
; 60(2): 291-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21193909
16.
Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro.
Front Immunol
; 12: 737988, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34721399
17.
Single-site, five-year experience with human eosinophil isolation by density gradient centrifugation and CD16 immunomagnetic negative separation.
BMC Res Notes
; 13(1): 211, 2020 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32276656
18.
Eosinophil and mast cell Siglecs: From biology to drug target.
J Leukoc Biol
; 108(1): 73-81, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31965606
19.
Discovery, Function, and Therapeutic Targeting of Siglec-8.
Cells
; 10(1)2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33374255
20.
Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
J Leukoc Biol
; 104(1): 11-19, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601103